KALBITOR is approved to treat hereditary angioedema (HAE) attacks in people 12 years of age and older. KALBITOR is not a cure for HAE.
KALBITOR is an on-demand treatment that targets plasma kallikrein.
People with HAE have a protein in their body called plasma kallikrein that is not controlled properly. KALBITOR inhibits the activity of this protein, which stops the production of bradykinin, to reduce the pain and swelling of an HAE attack.
People treated with KALBITOR showed significant improvement in HAE attack symptoms at 4 hours compared to patients who were treated with placebo.
KALBITOR injections should only be given by a doctor or a nurse with appropriate medical support to manage serious allergic reactions and HAE. For each dose, your doctor or nurse will inject KALBITOR just under your skin, away from the site of the attack and into the abdomen, thigh, or upper arm.
Serious allergic reactions have been known to occur in people treated with KALBITOR. These reactions can be life-threatening and usually happen within 1 hour after receiving KALBITOR. See potential side effects.
Please read the Medication Guide before you start receiving KALBITOR and before each treatment. There may be new information.